H. Minami

发表

Compound heterozygous group A xeroderma pigmentosum patient with a novel mutation and an inherited reciprocal translocation

K. Yoshikawa, H. Taguchi, T. Tanaka, 2000, The British journal of dermatology.

A preliminary report of the treatment of blue nevus with dermal injection of riboflavin and exposure to near-ultraviolet/visible radiation (ribophototherapy).

N. Sakakibara, T. Tsuji, K. Sato, 2000, Journal of dermatological science.

Elevated plasma superoxide dismutase activity in patients with systemic sclerosis.

N. Sakakibara, T. Tsuji, A. Morita, 1996, Journal of dermatological science.

PCR-RFLP analysis as an aid to genetic counseling of families of Japanese patients with group A xeroderma pigmentosum.

K. Yoshikawa, H. Taguchi, T. Maeda, 1997, The Journal of investigative dermatology.

Chronological difference in walking impairment among Japanese group A xeroderma pigmentosum (XP‐A) patients with various combinations of mutation sites

K. Yoshikawa, H. Taguchi, T. Maeda, 1995, Clinical genetics.

Severe neurological abnormalities associated with a mutation in the zinc‐finger domain in a group A xeroderma pigmentosum patient

K. Yoshikawa, H. Taguchi, T. Maeda, 1994, The British journal of dermatology.

The primary cytotoxicity in ultraviolet-a-irradiated riboflavin solution is derived from hydrogen peroxide.

K. Yoshikawa, H. Taguchi, T. Maeda, 1995, The Journal of investigative dermatology.

Hypoxia potentiates ultraviolet A-induced riboflavin cytotoxicity.

K. Yoshikawa, H. Kosaka, T. Tsuji, 1999, The Journal of investigative dermatology.

Anti‐desmoglein 1 antibody‐positive mother and antibody‐negative child with Darier's disease

H. Koga, K. Yoshiura, M. Jinnin, 2022, The Journal of dermatology.

Vitamin B6 phototoxicity induced by UVA radiation

K. Yoshikawa, H. Kosaka, T. Shiga, 2000, Archives of Dermatological Research.